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Abstract The accurate microbiological diagnosis of diar-
rhoea involves numerous laboratory tests and, often, the path-
ogen is not identified in time to guide clinical management.
With next-generation sequencing (NGS) becoming cheaper, it
has huge potential in routine diagnostics. The aim of this study
was to evaluate the potential of NGS-based diagnostics
through direct sequencing of faecal samples. Fifty-eight clin-
ical faecal samples were obtained from patients with diarrhoea
as part of the routine diagnostics at Hvidovre University
Hospital, Denmark. Ten samples from healthy individuals
were also included. DNA was extracted from faecal samples
and sequenced on the Illumina MiSeq system. Species distri-
bution was determined with MGmapper and NGS-based di-
agnostic prediction was performed based on the relative abun-
dance of pathogenic bacteria and Giardia and detection of
pathogen-specific virulence genes. NGS-based diagnostic re-
sults were compared to conventional findings for 55 of the
diarrhoeal samples; 38 conventionally positive for bacterial
pathogens, two positive for Giardia, four positive for virus
and 11 conventionally negative. The NGS-based approach
enabled detection of the same bacterial pathogens as the clas-
sical approach in 34 of the 38 conventionally positive bacterial
samples and predicted the responsible pathogens in five of the
11 conventionally negative samples. Overall, the NGS-based
approach enabled pathogen detection comparable to conven-
tional diagnostics and the approach has potential to be extend-
ed for the detection of all pathogens. At present, however, this
approach is too expensive and time-consuming for routine
diagnostics.
Introduction
Diarrhoea has a global disease burden estimated to encompass
1.7 billion cases each year, with 1.5 million deaths worldwide
attributed in 2012, and is the second most common cause of
death in young children [1, 2]. Diarrhoea is typically a symp-
tom of a gastrointestinal infection, but may also be a symptom
of several medical conditions or a result of drug treatment, e.g.
antibiotic-associated diarrhoea [3].
Diarrhoea of different infectious origin (bacterial, viral and
some parasitic) may be difficult to distinguish based on history
or clinical observations and, thus, rapid laboratory analyses
are important, since treatment and patient care depends on
the pathogen [1, 4, 5]. In addition, rapid and accurate diagnos-
tics, characterisation and comparison of pathogens are essen-
tial to identify both nosocomial and foodborne outbreaks.
However, diagnostic results are often not available in a timely
fashion and current methods employed are labourious, time-
consuming, costly, require significant expertise and result in
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the detection of pathogens in only a small fraction of exam-
ined samples [4, 5]. Thus, conventional diagnostics typically
only result in the identification of a minority of diarrhoea-
causing microbial agents, while up to 80% of cases remain
unresolved [6]. It is also well -known that some bacterial path-
ogens are difficult to grow or are even non-culturable, while
still being viable [7].
Polymerase chain reaction (PCR)-based methods for the
detection of enteropathogens from stool samples that are more
rapid and more sensitive than the conventional culturing pro-
cedures have been described [8–11]. The disadvantage of
using PCR may be that we are only detecting those agents
we are looking for and it is normally not possible to obtain
phylogenetic information.
Next-generation sequencing (NGS) has started to gain
ground in public health and clinical microbiology. NGS pro-
vides cost-efficient analysis and rapid turnaround time [12,
13]. It has already been used in clinical settings for elucidating
bacterial outbreaks [14–16] and it has been proposed for the
real-time typing and surveillance of pathogens [16–18].
NGS has, until recently, been employedmainly on bacterial
isolates. However, as demonstrated for urinary tract infections
[19], the technology can be applied directly to clinical sam-
ples, potentially advancing diagnostics and leading to even
more rapid diagnostic results. Furthermore, it was recently
demonstrated that the detection of Clostridium difficile by
NGS is correlated with the already existing laboratory testing
[20] and metagenomics sequencing has been employed on a
limited number of patient stool samples for the detection of
pathogens [21, 22]. In addition to species detection, NGS
offers detection of resistance and virulence genes, which can
further shorten the time needed for pathogen-directed treat-
ment to be initiated.
Here, we evaluated the use of NGS for the diagnostics of
diarrhoea by comparing direct NGS sequencing of human
faecal samples to the outcome of the conventional diagnostic
procedures on several bacterial pathogens.
Materials and methods
Faecal samples
Clinical faecal samples were included based on positive bac-
terial, viral or parasitological findings at the Department of
Clinical Microbiology at Hvidovre University Hospital in
Denmark. We included samples positive for C. difficile
(n = ∼15), Salmonella spp. (n = 4–6), Campylobacter spp.
(n = 2–4), Yersinia enterocolitica (n = 0–2), diarrhoeagenic
Escherichia coli (n = ∼10), Giardia intestinalis (n = ∼3), rota-
virus (n = ∼4) and norovirus (n = ∼4), as well as samples
(n = ∼15) obtained from diarrhoeal patients, with no microbi-
ological findings in the routine diagnostics. The samples were
collected from September to November 2013. As controls, we
included faecal samples from healthy adults participating in a
clinical randomised trial on the interactions between antibi-
otics and the gut microbiota conducted at Køge Hospital,
Denmark (local ethics committee journal number SJ-383).
Control samples were collected during June 2014 prior to
antibiotic treatment.
Faeces were stored either as whole faeces in 1 mL STAR
buffer or as the liquid solution from a FaecalSwab (Copan),
depending on how the sample had been submitted to the
Department of Clinical Microbiology for analysis. Bacterial
pathogens cultured from the samples were stored in broth with
10% glycerol. All faecal samples and isolates were stored at
−80 °C. For all included patients and healthy study partici-
pants, age and gender were registered, and for patients, the
information on occurrence of bloody diarrhoea was noted as
reported on the sample requisition form.
Conventional routine laboratory analysis
Routine conventional diagnostic tests were performed on all
samples and included conventional bacterial culturing for
enteropathogens as well as PCR for diarrhoeagenic E. coli
(DEC), toxigenic C. difficile, diarrhoeagenic viruses and in-
testinal parasites. DEC PCR was conducted on the isolated
E. coli by in-house conventional multiplex PCR, detecting
A/EEC: intimin (eae); EPEC: A/EEC (eae) with classical
EPEC serotype (O26, O103, O111, O145, O157, O55,
O119, O125ac, O127, O128ab, O86, O114, O121, O126 or
O142); VTEC: verocytotoxin 1 and 2 (vtx1, vtx2); ETEC:
heat-stable (ST) enterotoxin (estA) and heat-labile (LT) entero-
toxin (eltA); EIEC: invasive plasmid antigen (ipaH); and
EAEC: transcriptional activator (aggR) [23].
For C. difficile, real-time PCR was conducted directly on
faecal samples according to an in-house protocol for the de-
tection of toxin A (tcdA), toxin B (tcdB), binary toxin (cdtA)
and for mutation (Δ117) in the regulator tcdC [24].
The diarrhoeagenic viruses were examined directly on fae-
cal samples by an in-house real-time PCR covering norovirus
(genotypes I and II), sapovirus (genotypes I, II and V), ade-
novirus F (serotypes 40 and 41) and rotavirus (A and C).
The presence of intestinal parasites was examined by stool
microscopy and additionally by a multiplex real-time PCR
assay employing the LightMix Modular Assay (TIB
MOLBIOL GmbH, Germany) for Entamoeba histolytica,
G. intestinalis, Cryptosporidium sp. and Dientamoeba
fragilis.
DNA isolation and sequencing
DNA was isolated from the entire amount of stored faecal
samples using the QIAamp DNA Stool Kit (Qiagen,
Denmark) for the isolation of DNA for pathogen detection
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with slight modifications. In the initial lysis step (3), an addi-
tional 5 min of incubation at 95 °C was performed and in the
final step (18), elution was done with 100 μL Buffer AE.
DNA purification from bacterial isolates was done employing
the Easy-DNA Kit (Invitrogen, Denmark), according to the
manufacturer’s protocol. The DNA concentrations were mea-
sured with the Qubit® dsDNA HS and Qubit® dsDNA BR
Assay Kits (Invitrogen) and DNA libraries were constructed
using the Nextera XTDNA Sample Preparation Kit (Illumina,
Denmark), according to the manufacturer’s protocol.
Sequencing was performed on the MiSeq system (Illumina),
employing theMiSeqReagent Kit v2 (Illumina) for 500 cycles
(2 × 250 bp) for patient samples and bacterial isolates, where-
as control samples were sequenced employing the MiSeq
Reagent Kit v3 (Illumina) for 600 cycles (2 × 300 bp). Four
samples were sequenced per MiSeq run.
Five of the samples (S_127, S_164, H_107, H_108 and
H_110) were sequenced from both purification of faeces and
faecal swabs to ensure comparability.
All sequences of metagenomic samples, with human DNA
removed, as well as sequences of isolates, have been deposited
at ENA (PRJEB14038).
Analysis of sequencing results
(i) Species confirmation and virulence profiling of isolate
sequences
The isolate sequences included in the study were sub-
jected to species identification employing KmerFinder
1.3 [19, 25]. Additional information on this method is
included in Supplemental File 1. All isolate sequences
were examined for the presence of selected virulence
genes for E. coli (aggR, astA, eae, eltA, eltB, estA,
stx1A, stx1B, stx2A, stx2B), Shigella spp. (ipaB, ipaC,
ipaD, ipaH7.8, ipaH9.8, mxiA, stxA, stxB, virA),
C. jejuni (cdtA, cdtB, cdtC, ciaB, flaA, flaB, flaC),
C. difficile (cdtA, cdtB, tcdA, tcdB), S. enterica (invA,
invB, invE, invG, invH, invJ, sseA, sseB, sseC, sseD,
sseE) and Y. enterocolitica (inv, ystA) using MGmapper
(https://cge.cbs.dtu.dk/services/MGmapper), mapping
against the Virulence Factors Database (http://www.
mgc.ac.cn/VFs/) [26, 27]. For the available isolates, the
proportion of the genome sequence within the
corresponding faecal sample was determined.
(ii) Metagenomic analysis and species distribution in faecal
samples
The distribution of species within the faecal samples
was determined using MGmapper (https://cge.cbs.dtu.
dk/services/MGmapper/) [26]. Specifically, paired-end
reads from each metagenome sample were mapped
against six databases: human genomes, parasite ge-
nomes, complete bacterial genomes, as well as draft bac-
terial genomes, obtained from GenBank (http://www.
ncbi.nlm.nih.gov/genbank/), Virulence Factor (http://
www.mgc.ac.cn/VFs/) [28] and VirulenceFinder [17].
Additional information on this method is included in
Supplemental File 1.
The composition of organisms was evaluated by the
number of reads mapping to all individual organisms.
The relative abundance of human, bacterial and
parasitic DNA, as well as that of defined pathogens
(S. enterica, Y. enterocolitica, E. coli, C. jejuni,
C. difficile, Shigella and G. intestinalis) was calculated
as the percentage of reads (of total reads in the sample)
mapping to the particular pathogen or group (human,
bacterial or parasitic). For each of the specific
pathogens, the relative abundance of the pathogen was
determined for: (1) patients with diarrhoea caused by the
particular pathogen, (2) patients with diarrhoea where
the particular pathogen was not detected by conventional
methods and (3) healthy controls, all according to con-
ventional diagnostics. Similarly, the relative abundance
of pathogens was also examined for the conventionally
negative samples and the samples where only viral path-
ogens were determined by conventional diagnostics.
Additionally, for each of the specific pathogens, the ratio
between the relative abundance of the pathogen and
Shannon’s diversity index of the sample was determined.
Differences in relative abundance between samples
collected as faeces and swabs were assessed by compar-
ing the relative abundance within the samples of all de-
tected hits, on the species level, covering all employed
MGmapper databases. Interquartile ranges (IQRs) and
upper fence values were calculated for each of the path-
ogens of interest in both control samples and diarrhoea
samples from other pathogen origin. The size of the IQR
(Q3 − Q1) indicates how spread the middle half of the
data is. Q3 + 1.5×IQR was used as a measure (the upper
fence) to identify values that were much farther away
from the centre (outliers). An NGS-based case diagnosis
was assigned to a sample if: (1) the relative abundance of
the pathogen was higher than the upper fence (Q3 +
1.5×IQR) of the control samples and also higher than
the upper fence (Q3 + 1.5×IQR) of diarrhoea samples
from other pathogen origin (together referred as the
threshold) or (2) pathogen-specific virulence factors
were detected.
(iii) Typing of E. coli and C. difficile by direct sequencing
To evaluate the possibility of performing bacterial
typing by direct sequencing, samples conventionally
positive for E. coli or C. difficile and the corresponding
isolates were subjected to phylogenetic analysis
employing the tool NDtree, which infers phylogenies
based on the number of nucleotide differences between
isolates. Phylogenies were inferred for E. coli and
C. difficile, employing the reference strains E. coli
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O157:H7 str. Sakai (accession number NC_002695.1)
and Peptoclostridium difficile 630 (accession number
NC_009089.1), respectively. NDtree was employed as
described by Joensen et al. [17], with the z-score param-
eter set to 1.96 and the mode set to pairwise comparison.
Results
Collected faeces samples
In total, 58 patient samples and ten samples from healthy
individuals were collected and included in the study
(Table 1). In 45 of the patient samples, one or more pathogens
had been identified by the routine diagnostics: 39 with bacte-
ria, nine with viruses and two with parasites. Some samples
contained more than one pathogen: seven different bacterial
species and three samples had multiple DEC. Five samples
contained both bacterial and viral pathogens. Thirteen patient
samples were initially included, which were negative accord-
ing to the conventional diagnostic tests. The median age of the
patients was 47.5 years (range 0–95 years) and 36 patients
(62%) were female. In the control group, the median age
was 38 years (range 23–56 years) and 60% were female.
Nine patients had bloody diarrhoea, 33 had non-bloody diar-
rhoea and for 13 patients, no information was available.
DNAwas purified from all 58 patient faecal samples except
for three with too low levels of DNA for detection. Two of
these samples were conventionally negative (S_116 and
S_117) and one was C. difficile-positive (S_108), and, thus,
further analysis was performed on 55 samples. The DNA pu-
rifications ranged in concentrations from 0.12 to 50.2 μg/μL,
with the DNA isolations from pure faeces giving the highest
yields. The raw sequence output from the patient samples
ranged from 125.05 Mb (sample S_136) to 4.26 Gb (sample
S_160) and between 1.53 Gb (H_102) and 6.93 Gb (H_111)
for healthy controls.
Abundance of pathogens in faeces samples
Figure 1 shows the relative abundance of bacterial, human and
parasitic DNA for all samples. The relative abundance of bac-
teria ranged between 46 and 71% for the samples from healthy
controls and between 6 and 96% for patient samples. Human
DNA content ranged from 0 to 1% in healthy control samples
and from 0 to 91% for patient samples. The relative abundance
for parasite DNA was low, with only a few sequence reads
mapping to parasite sequences for both healthy controls and
patients. A large proportion of reads did not map to any se-
quences present in the databases.
The sampling method employed was not found to have an
effect on the relative abundance of species detected in the
samples, as evaluated on five samples with DNA extracted
from both pure faeces and faecal swabs.
Figure 2 shows the relative abundance of Giardia,
Salmonella, Y. enterocolitica, E. coli, C. jejuni, C. difficile
and Shigella for samples positive for the particular pathogen
by conventional diagnostics, compared to healthy controls
(see variation of controls in Supplemental Fig. 1) and to the
level detected in diarrhoeal samples of other pathogenic ori-
gin. The abundance upper fence of the different pathogens
varied, with the upper fence of diarrhoea samples from other
pathogen origin ranging from 0.00% for G. intestinalis to
44.18% for E. coli, with Campylobacter (0.01%),
Y. enterocolitica (0.03%), C. difficile (0.10%), Salmonella
(0.57%) and Shigella (0.73%) in between. In the healthy con-
trols, the upper fences were:Giardia (0.00%), E. coli (0.16%),
C. jejuni (0.02%), Y. enterocolitica (0.00%), C. difficile
(0.14%), S. enterica (0.00%) and Shigella (0.02%).
For S. enterica, all five conventionally positive samples were
above the abundance upper fence in the healthy control samples.
However, only three were also above the upper fence detected in
other non-Salmonella diarrhoea samples and, therefore, above
the threshold set for NGS-based diagnostics on the basis of
relative abundance. These three samples contained detectable
Salmonella virulence genes (invA, invB, invE, invG, invH,
invJ, sseB, sseC, sseE), while one of the Salmonella-positive
samples (S_127) below the threshold also contained two reads
mapping to invG. In the last conventionally positive sample
(S_129), neither relative abundance nor virulence genes indicat-
ed the presence of Salmonella. Salmonella virulence genes were
detected in one sample (S_119) from a diarrhoea patient consid-
ered negative by all the conventional diagnostic tests.
For C. difficile, seven of the 13 conventionally positive
samples were above the upper fence for non-C. difficile
diarrhoeal samples, but above the level of the healthy controls.
In ten of these, sequence reads mapping to C. difficile viru-
lence genes (cdtA, cdtB, tcdA, tcdB) were detected.
Clostridium difficile virulence genes were not detected among
other samples except one Salmonella-positive sample
(S_128), in which two reads mapping to cdtB were found.
The 15 conventionally DEC-positive E. coli samples varied
considerably in their relative abundance of E. coli sequence
(from 0.7 to 80%), and although the abundance was higher
than the upper fence for the healthy controls, all but one of the
samples were below the level of E. coli detected in non-E. coli
diarrhoeal samples. However, sequences of E. coli virulence
genes (stx1A, stx1B, eae, astA, eltA, eltB, aggR, estA) were
detected in 14 of the 15 samples, excluding S_158. The E. coli
virulence genes were generally not found in other samples.
However, a few astA reads were detected in three samples of
other pathogen origin (S_104, S_107, S_129) and in one
healthy control (H_108), while the eae gene was detected in
three samples not found to be E. coli-positive by conventional
diagnostics (S_127, S_135, S_163).
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Both Shigella-positive samples were below the upper fence
defining the non-Shigella diarrhoeal samples, and above the
level in the healthy controls. In both samples, however,
Shigella virulence genes (virA, mxiA, ipaH7.8, ipaH9.8,
ipaB, ipaD) were detected. Shigella virulence genes were
not detected in any other faecal samples. For the five samples
which tested positive forC. jejuni in conventional diagnostics,
three had a relative abundance above the upper fence of both
the control group and non-C. jejuni diarrhoeal samples.
However, for all five samples,Campylobacter virulence genes
(ciaB, flaA, flaB, flaC, cdtA, cdtB, cdtC) were detected. Few
Campylobacter virulence genes were detected in five samples
that were not found to be Campylobacter-positive by conven-
tional diagnostics: one positive for norovirus (S_135), three
negative by conventional diagnostics (S_114, S_118, S_119)
and one a healthy control (H_111).
For the two samples positive for Y. enterocolitica, the rela-
tive abundance was very different. One sample (S_143)
contained around 0.5% Y. enterocolitica, which was just above
the upper fence for the other diarrhoeal samples, while the
other (S_164) had more than 23% Y. enterocolitica.
Sequence reads mapping to virulence genes (inv, ystB) were
detected in both samples and Yersinia virulence genes were not
detected in any other samples. Both G. intestinalis-positive
samples were very low in abundance (below 0.01%), contain-
ing only a few reads mapping to Giardia. None of the other
diarrhoeal samples contained Giardia sequences, whereas two
healthy controls (H_103, H_107) contained a few reads.
The complete distribution of bacteria within the samples is
included in Supplemental Fig. 2.
Similar detection of the pathogens in the faecal samples
was performed using the relative abundance of the pathogen
with the respect to the Shannon’s diversity index of the sam-
ple. The results are comparable with pathogen detection, de-
scribed above, and are shown in Supplemental Fig. 3. Using
this measure, the S. enterica sample S_126 moved below the
upper fence detected in other non-Salmonella diarrhoea sam-
ples. However, two E. coli samples (S_140, S_153) appeared
above the upper fence detected in other non-Escherichia diar-
rhoea samples.
Table 1 Findings in faecal samples by conventional diagnostic methods
Pathogen Number of samples Sample ID
Bacterial
Clostridium difficile 14a (13) S_105, S_106, S_107, S_108a, S_130, S_134, S_136,
S_137, S_149, S_160B, S_162, S_164, S_165, S_166
Salmonella enterica subsp. enterica 5 S_126, S_127, S_128, S_129, S_153B
Shigella spp. 2 S_144B, S_152B
Campylobacter jejuni 5 S_102B, S_103, S_104, S_132B, S_138B
Yersina enterocolitica 2 S_143, S_164
DEC-positive Escherichia coli 15 S_110*, S_130, S_132B, S_140, S_141, S_142, S_145,
S_148, S_151, S_153B, S_154*, S_156*, S_157, S_158, S_159
DEC-positive E. albertii 1 S_148
Aeromonas spp. 1 S_126
Providencia alcalifaciens 1 S_140
Viral
Sapovirus 2 S_130, S_131
Norovirus 5 S_126, S_133, S_135, S_149, S_150
Rotavirus 1 S_148
Adenovirus 2 S_132B, S_148
Parasitic
Giardia intestinalis 2 S_111, S_ 155
Negative 13a (11) S_114B, S_115, S_116a, S_117aB, S_118, S_119, S_120,
S_121, S_122, S_123, S_124, S_161B, S_163
Healthy controls 10 H_101, H_102, H_103, H_104, H_105, H_106,
H_107, H_108, H_110, H_111
Samples where more than one pathogen was detected by conventional diagnostics are in bold. Samples from patients with bloody diarrhoea are marked
with superscript B . Non-primary pathogens are underlined. An asterisk (*) denotes samples where two different DECs were isolated from conventional
diagnostics
a Three samples (S_108, S_116 and S_117) were collected for the study but not included in the final analysis since not enough DNA could be purified
from the samples
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Fig. 2 Relative abundance of pathogens in samples positive by
conventional diagnostics. For each pathogen (Giardia, Salmonella,
Y. enterocolitica, E. coli, C. jejuni, C. difficile and Shigella), the fraction
of reads mapping to the pathogen is plotted for all samples positive by
conventional diagnostic methods. The orange dots indicate the presence
of pathogen-specific virulence genes as determined by NGS analysis,
while the green dots indicate the absence. The upper fence (Q3 +
1.5×IQR) of the relative abundance for the healthy controls and for the
diarrhoea samples where the particular pathogen was not detected by
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Fig. 1 Abundance of bacterial, parasitic and human DNA among faecal
samples. For each group of samples, healthy, patients with bloody
diarrhoea and patients with non-bloody diarrhoea (or unknown), the
fraction of reads mapping to bacteria, parasites and human reference
genomes is shown. The abundance is normalised according to the total
number of reads in each specific sample
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Detection of pathogens in conventionally negative samples
Figure 3 shows the abundance of pathogens and the pres-
ence of virulence factors for the 11 sequenced convention-
ally negative samples and the four samples where only
viral pathogens were determined by the conventional di-
agnostics. None of these sample contained Giardia,
C. difficile or Shigella. One sample (S_120) was above
the threshold in Salmonella relative abundance, whereas
another (S_119) contained reads mapping to Salmonella
virulence genes invA and invE. Campylobacter was detect-
ed in four samples, where virulence genes were detected in
three negative samples (S_114, S_118, S_119) and one
positive for norovirus (S_135).
For E. coli, four samples (S_118, S_119, S_121, S_135)
were above the threshold and E. coli virulence gene eae was
detected in two samples (S_135, S_163). Only one sample
(S_120) was above the threshold for Y. enterocolitica, but no
virulence genes were detected.
The analysis of negative samples using the ratio between
the relative abundance and Shannon’s diversity index showed
similar results (Supplemental Fig. 4).
Comparison of results obtained from conventional
diagnostics and direct sequencing of faecal samples
In Table 2, the similarities and discrepancies between the con-
ventional findings and the NGS-based findings on faecal sam-
ples are listed, covering all samples included in the study. The
NGS approachwas able to identify pathogens in agreement with
conventional diagnostics in 34 of the 38 samples (Table 2). Five
of these samples (S_130, S_132, S_153, S_154 and S_164)
were conventionally positive for two different bacterial patho-
gens, with correct identification of both by the NGS approach.
However, for four samples (S_129, S_136, S_149 and S_158),
neither abundance nor virulence factors indicated the presence
of the pathogens identified by the conventional diagnostics (one
S. typhimurium, two C. difficile and one ETEC).
The NGS approach, on the other hand, was able to detect
additional bacterial pathogens in samples positive for other
pathogens by conventional diagnostic testing and in samples
that had been tested negative. Of the 38 conventionally posi-
tive bacterial diarrhoea samples, two (S_127, S_128) were
found to contain additional pathogens by the NGS approach
(Table 2). In the conventionally negative diarrhoea samples,
Fr
ac
tio
n 
of
 th
e 
re
ad
s 
(%
)
0.0e+00
5.0e−06
1.0e−05
1.5e−05
Giardia intestinalis
S
_1
14
S
_1
15
S
_1
18
S
_1
19
S
_1
20
S
_1
21
S
_1
22
S
_1
23
S
_1
24
S
_1
31
S
_1
33
S
_1
35
S
_1
50
S
_1
61
S
_1
63
Fr
ac
tio
n 
of
 th
e 
re
ad
s 
(%
)
0.2
0.4
0.6
0.8
Salmonella enterica
S
_1
14
S
_1
15
S
_1
18
S
_1
19
S
_1
20
S
_1
21
S
_1
22
S
_1
23
S
_1
24
S
_1
31
S
_1
33
S
_1
35
S
_1
50
S
_1
61
S
_1
63
Fr
ac
tio
n 
of
 th
e 
re
ad
s 
(%
)
0.000
0.005
0.010
0.015
0.020
0.025
0.030
Yersinia enterocolitica
S
_1
14
S
_1
15
S
_1
18
S
_1
19
S
_1
20
S
_1
21
S
_1
22
S
_1
23
S
_1
24
S
_1
31
S
_1
33
S
_1
35
S
_1
50
S
_1
61
S
_1
63
Fr
ac
tio
n 
of
 th
e 
re
ad
s 
(%
)
0.000
0.005
0.010
0.015
Campylobacter jejuni
S
_1
14
S
_1
15
S
_1
18
S
_1
19
S
_1
20
S
_1
21
S
_1
22
S
_1
23
S
_1
24
S
_1
31
S
_1
33
S
_1
35
S
_1
50
S
_1
61
S
_1
63
Fr
ac
tio
n 
of
 th
e 
re
ad
s 
(%
)
0.02
0.04
0.06
0.08
0.10
0.12
0.14
Clostridium difficile
S
_1
14
S
_1
15
S
_1
18
S
_1
19
S
_1
20
S
_1
21
S
_1
22
S
_1
23
S
_1
24
S
_1
31
S
_1
33
S
_1
35
S
_1
50
S
_1
61
S
_1
63
Fr
ac
tio
n 
of
 th
e 
re
ad
s 
(%
)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Shigella
S
_1
14
S
_1
15
S
_1
18
S
_1
19
S
_1
20
S
_1
21
S
_1
22
S
_1
23
S
_1
24
S
_1
31
S
_1
33
S
_1
35
S
_1
50
S
_1
61
S
_1
63
Fr
ac
tio
n 
of
 th
e 
re
ad
s 
(%
)
20
40
60
80
Escherichia coli
S
_1
14
S
_1
15
S
_1
18
S
_1
19
S
_1
20
S
_1
21
S
_1
22
S
_1
23
S
_1
24
S
_1
31
S
_1
33
S
_1
35
S
_1
50
S
_1
61
S
_1
63
No Virulence genes
Virulence genes
Healthy upper fence
Upper fence in other diarrheal samples
Fig. 3 Relative abundance of pathogens in samples negative by
conventional diagnostics. For samples that were either negative or
virus-positive by conventional diagnostics, the fraction of reads mapping
to each pathogen (Giardia, Salmonella, Y. enterocolitica, E. coli,
C. jejuni, C. difficile and Shigella) was plotted. The orange dots indicate
the presence of pathogen-specific virulence genes, while the green dots
indicate the absence. The upper fence (Q3 + 1.5×IQR) of the relative
abundance for healthy controls and for the diarrhoea samples where the
particular pathogen was not detected by conventional methods are shown
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pathogens were detected in five of the 11 sequenced samples,
as well as in one of the conventionally virus-positive samples
(Table 2).
In two conventionally positive samples (S_127, S_135),
E. coli was identified as an additional pathogen by the detec-
tion of reads mapping to E. coli virulence gene eae encoding
intimin. Similarly, in three other conventionally positive sam-
ples (S_104, S_107, S_129), reads mapping to the virulence
gene astA were detected, and this virulence gene was also
detected in one healthy control sample (H_108). However,
the detection of this gene alone was considered insufficient
for pathogen prediction, since astA can be present in healthy
individuals [29].
Campylobacter jejuni was detected as an additional patho-
gen in one sample (S_135) that was conventionally positive
for another pathogen and in three samples (S_114, S_118,
S_119) considered negative. Campylobacter jejuni virulence
gene flaAwas detected in one healthy control sample (H_111).
Salmonella entericawas detected as an additional pathogen in
one sample (S_135) conventionally positive for another path-
ogen and in two negative samples (S_119, S_120), while
C. difficile was not detected in any of the conventionally neg-
ative samples.
Detection of isolate sequence within the metagenomic
sample
For 35 of the 38 patient samples with bacterial findings by
conventional diagnostics, the percentage of the isolate covered
by reads in the metagenomic sample ranged between 2 and
100%, as illustrated in Fig. 4. Three samples were not includ-
ed in this analysis due to unavailability of the isolate (S_137,
S_149) and an isolate sequence file error (S_142).
Detection of virulence genes
All virulence genes found in E. coli by conventional PCR
were also detected by NGS on single isolates (Table 3), in
addition to many more. Not all virulence genes found in the
single isolates were observed in the metagenomics data.
Typing of E. coli and C. difficile by direct sequencing
A phylogenetic tree for E. coli, including the metagenomic
sequences and isolate sequences, is illustrated in Fig. 5. The
tree shows clear matches between most metagenomic samples
and their respective isolates. For C. difficile, the data output
was very low, with only 2–49% of the C. difficile genomes
being represented in the metagenomic samples, and, thus, it
was not found to be sufficient for the construction of a mean-
ingful phylogenetic tree.
Discussion
Accurate and rapid diagnostics of human pathogens are im-
portant in order to direct treatment of infectious disease and
prevent possible outbreaks. Faeces is a complex material con-
taining high numbers of different bacteria, different clones
within the same species, commensals and potential pathogens.
Thus, an NGS diagnostic approach, as with any other diag-
nostic approach, requires the ability to detect the presence of
potential pathogens as well as the ability to differentiate be-
tween potential pathogens and their commensal variants. This
is a complicated process as some species, e.g. E. coli, can be
both, and since healthy persons can sometimes be asymptom-
atic carriers of otherwise pathogenic bacteria. Therefore, the
interpretation of test results needs to take patient symptoms
and previous treatment, as well as knowledge of the epidemi-
ology of pathogens, into account. This study showed that di-
rect sequencing of faecal samples is a new method for identi-
fying faecal pathogens from patients with diarrhoea.We found
that the NGS approach was able to identify the majority of
bacterial pathogens identified by conventional diagnostic
methods (34 of 38 samples). The NGS approach further de-
tected bacterial pathogens that were probably responsible for
the diarrhoeal disease in five of the 11 clinical samples in
which no pathogens could be detected by conventional diag-
nostics and in four samples where other pathogens had been
detected. This has the potential to affect patient management.
Additionally, the NGS approach was able to assign the correct
pathotype for the diarrhoeagenic E. coli by detection of the
pathotype-specific virulence genes. In this pilot study, we used
a threshold based on the upper fence abundance observed in
diarrhoeal samples and controls, respectively, together with
the detection of specific virulence genes. This approach might
be too sensitive and possibly associated with false-positive
samples, potentially leading to unnecessary treatment. Thus,
before implementing this shotgun metagenomic approach in
the clinical setting, further studies are required, which enable a
proper definition of the threshold for relative abundance and
the detection of virulence genes (i.e. number of reads needed,
percentage of the gene covered). Furthermore, when using the
conventional identification as criteria, there is a risk that mis-
takes might include positive samples in the control group. As
the number of samples increases, this is, however, expected to
cause limited problems. Ideally, future studies should be car-
ried out under field conditions, i.e. in clinical settings, and lead
to a definition of a threshold corresponding to where treatment
leads to cure of the patient.
Campylobacter jejuni was the most common pathogen de-
tected in the samples from patients with diarrhoea found to be
negative by conventional methods.Campylobacter are known
to be difficult to culture, and it has previously been found that
PCR methods were able to detect Campylobacter species in
culture-negative samples, probably as a result of decreased
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viability of the cells [30]. Although uncultivable,
Campylobacter DNA would have been detectable by direct
sequencing of the samples and it is, therefore, reasonable to
assume that the conventionally (culture) negative samples
were from Campylobacter infections. Salmonella was also
found more often by the NGS approach than by culturing.
The identification of Salmonella in the laboratory is based
on colony identification on enteric medium, and recognition
requires skilled personnel. Therefore, Salmonella may be
under-diagnosed by conventional methods, but reduced via-
bility, as for C. jejuni, may also play a role.
Escherichia coli was also found more often by NGS than
by conventional diagnostics, and because E. coli is also a
commensal, the NGS detection relied solely on well-known
virulence genes, where specifically eae was found, which is
also targeted by PCR in the conventional diagnostics.
However, as E. coli is abundant in the samples, probably with
several strains simultaneously, one explanation for the dis-
crepancy could be that the eae-containing strain was never
the one to be subjected to PCR in the conventional diagnostic.
For most of the pathogens examined, the relative abun-
dance worked well for the case definition of a proportion of
the samples, while for some samples, the detection of
pathogen-specific virulence genes was necessary for identify-
ing the pathogen. For both E. coli and Shigella, the relative
abundance of the bacteria alone was not considered sufficient
for a positive finding by our method, as sequences specific for
these pathogens were just as abundant among negative sam-
ples as those that were conventionally positive. Shigella is not
a commensal, but from a taxonomic perspective, it is a mem-
ber of the E. coli species [31]. Thus, sequence similarities
between Shigella and E. coli could be distorting the picture.
However, the detection of Shigella-specific and E. coli-specif-
ic virulence genes worked well.
Limitations of the NGS approach for diagnostics relates to
the extent of the databases used for mapping, since only path-
ogens included in the databases can be detected. This may
explain why six samples which were negative by conventional
methods remained negative by NGS analysis, where only
C. jejuni, S. enterica, E. coli, Shigella, C. difficile and
Giardia were specifically targeted. Thus, it is probable that
other diarrhoeagenic organisms could have been missed.
However, the patients could have also suffered from non-
infectious diarrhoea. The NGS method can be further im-
proved in the future by expansion of the databases to include
more diarrhoeagenic pathogens and specific targets.
The inability to detect the responsible bacterial pathogen by
our method in four of the conventionally positive samples was
most likely a result of too little sequence data. For C. difficile,
this might be caused by the DNA purification method used,
which might not be optimal for DNA obtained from Gram-
positive species. Thus, in future studies, an optimised proce-
dure should be employed [32]. Also, the large variation in the
amount of pathogen sequences detected in the samples, and
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Fig. 4 Isolate detection within metagenomic samples. Reference
mapping of reads from the metagenomic sample against the isolate
sequence from the specific sample was employed to assess the
percentage of the isolate covered by the metagenomic sequencing.
Also, the fraction of reads within the metagenomic sample that were
used in mapping is illustrated, as well as the total number of reads
present in the metagenomic sequences
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Table 3 Virulence factors detected by PCR or sequencing of single isolates and by metagenomics
Sample Pathogen Virulence genes found by
PCR*
Virulence genes found in isolate and
metagenome
Missing in
isolate
Missing in metagenome,
but found in isolate
S_102 C. jejuni flaA, ciaB, cdtA, flaB, cdtB, flaC, cdtC cdtC
S_103 C. jejuni cdtB, flaB, flaC, flaA, cdtC, cdtA, ciaB
S_104 C. jejuni flaA, cdtC, ciaB, cdtA, cdtB, flaB, flaC
S_105 C. difficile cdtB, cdtA, tcdB, tcdA
S_106 C. difficile cdtB, tcdB, tcdA cdtA
S_107 C. difficile tcdB, tcdA, cdtB cdtA
S_110 E. coli eae, stx1A eae, stx1B, stx1A astA stxB, stxA
S_126 S. enterica invH, invE, invG, invA, sseE, sseC,
invJ, invB
sseA, sseB, sseD
S_127 S. enterica invG invJ, invE, sseD, sseB, sseC,
sseA, invA, sseE, invH, invB
S_128 S. enterica invA sseC, sseB, sseD, invE, invJ,
invG,
sseA, invB, invH, sseE
S_129 S. enterica sseD, invJ, invE, sseC, sseB,
invA, sseA, invG, invH, invB,
sseE
S_130 E. coli eae eae, astA
S_132 E. coli stx1A stx1A eae stx1B, stxA, stxB
S_134 C. difficile tcdB, tcdA, cdtB cdtA
S_136 C. difficile tcdB, cdtA, tcdA, cdtB
S_138 C. jejuni flaB cdtB, cdtA, flaA, cdtC,
ciaB, flaB, flaC
S_140 E. coli eae eae eltA
S_141 E. coli eae eae
S_142 E. coli eltA, astA, eltB
S_143 Y. enterocolitica inv ystB
S_144 Shigella ipaH7.8, ipaH9.8, mxiA, virA,
ipaB
ipaD, ipaC
S_145 E. coli astA, eltA eltB, astA, eltA
S_148 E. coli eae eae
S_151 E. coli astA astA eae, eltB, aggR
S_152 Shigella ipaH7.8, virA, ipaB, ipaH9.8,
mxiA, ipaD
ipaC
S_153 E. coli eae eae
S_153 S. enterica sseB sseD, invE, invJ, sseC,
invA, invG, sseA, invB, invH,
sseE
S_154 E. coli aggR aggR eae, astA
S_156 E. coli eae astA, eae sta, aggR
S_157 E. coli astA, eltA astA, eltB, eltA
S_158 E. coli astA astA
S_159 E. coli astA, eltA eltB, astA, eltA eae
S_160 C. difficile cdtB, tcdA, tcdB cdtA
S_162 C. difficile tcdA, cdtB cdtA, tcdB
S_164 C. difficile tcdB, tcdA, cdtB cdtA
S_165 C. difficile cdtB, tcdB, cdtA, tcdA
S_166 C. difficile tcdA, cdtA, tcdB, cdtB
*Only for E. coli
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the percentage of the bacterial genomes covered by reads of
the metagenomic sequencing, reflected the variations in the
sequence output. For future analyses, these types of samples
should be sequenced deeper to ensure obtainment of enough
sequence data to properly detect the responsible pathogen,
despite the pathogen often constituting only a small fraction
of the DNA purified from the samples. Specifically, there is a
huge variation in the amount of human DNA present, as well
as some of the potential pathogens, e.g. C. difficile and
C. jejuni are present in very low abundance. More sequence
data should be obtained per sample in future analyses, which
should also evaluate larger sets of samples and target more
pathogens.
Our NGS approach did not allow for detection of the viral
pathogens that had been found by conventional diagnostic
testing, as most of the viral pathogens were RNA viruses,
which were not targeted by the DNA purification method
employed in our study. However, the NGS approach could
be expanded to include RNA purification from stool samples
and construction of specific databases for virus diagnostics.
Furthermore, parasite detection was inadequate, as only a few
complete parasite genome sequences were available to be ref-
erenced in MGmapper. However, we did construct a custom
database of parasite draft genomes for the detection ofGiardia
sequences, and further development of this database will im-
prove the diagnosis of parasite infections.
In addition to providing pathogen identification, direct
sequencing can also offer extensive additional information
on, for instance, virulence and resistance genes, or the pres-
ence of other pathogens, e.g. fungi and DNA viruses, which
can be extracted from the data. Also, non-culturable patho-
gens can potentially be identified. Our NGS approach
showed the potential of performing bacterial typing from
direct sequencing, as E. coli-positive samples showed almost
S_110 isolate (A/EEC)
S_156 isolate (EPEC)
S_130 sample
S_154 sample
S_154 isolate (EAEC)
S_158 isolate (ETEC)
S_151 sample
S_151 isolate (ETEC)
S_110 isolate (VTEC)
S_110 sample
S_142 sample
S_142 isolate (ETEC)
S_140 sample
S_140 isolate (EPEC)
S_159 sample
S_132 sample
S_157 sample
S_159 isolate (ETEC)
S_157 isolate (ETEC)
S_145 sample
S_145 isolate (ETEC)
S_156 isolate (A/EEC)
S_154 isolate (A/EEC)
S_148 sample
S_148 isolate (A/EEC)
S_132 isolate (VTEC)
S_153 sample
S_153 isolate (A/EEC)
S_158 sample
S_141 sample
S_141 isolate (A/EEC)
S_156 sample
Fig. 5 Phylogenetic relationships among metagenomic samples and
isolates. An NDtree is shown for E. coli. The tree was constructed by
mapping isolate WGS sequences and complete metagenomic sequences
against the reference E. coli O157:H7 str. Sakai. Escherichia coli
pathotypes are shown in parentheses on isolates
1336 Eur J Clin Microbiol Infect Dis (2017) 36:1325–1338
perfect phylogenetic clustering with their corresponding iso-
lates. We did not investigate whether it was possible to infer
phylogenies when only including metagenomics data, but
the results suggest that metagenomics data may, as a mini-
mum, be used in combination with single isolates for more
rapid elucidation and tracking of outbreaks. Typing could
probably be improved for both pathogens by obtaining more
sequences per sample.
The findings in this study indicate a future value of direct
sequencing of clinical faecal samples for diagnostic pur-
poses. This method may still be considered too labourious
and expensive for routine use in clinical settings where tens
of thousands of samples have to be processed annually.
However, the costs associated with the current conventional
diagnostics and failure to identify the causative agent in a
large part of the samples should not be ignored.
Furthermore, as prices and turnaround times for NGS are
declining, this type of analysis may become available in
first-line diagnostic setups offering rapid diagnostics and
providing valuable information to help direct patient treat-
ment. No estimates of turnaround time or costs associated
with conventional diagnostics or our meta-genomic ap-
proach was calculated. However, for single targets, i.e. iso-
lates, we recently compared WGS and the conventional ap-
proach for surveillance of VTEC and found WGS to be both
cheaper and faster [17]. Further studies also including eco-
nomical calculations, including those associated with de-
layed diagnostics and increased morbidity and mortality,
are called for.
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